CLINICAL_TRIALS
trial_result
· 2013-05-06
Clinical Trial Update: Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome [Phase 3]
Summary
Open-label Phase 3 study evaluating the safety and effectiveness of clobazam in Lennox-Gastaut Syndrome.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lundbeck LLC | Conditions: Lennox-Gastaut Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2013-05-06